Type 1 Diabetes Adolescents for Healthier Lifestyles Study
Launched by THE MIRIAM HOSPITAL · Mar 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Type 1 Diabetes Adolescents for Healthier Lifestyles Study, also known as the T1DAL program, is researching how to help teenagers with type 1 diabetes (T1D) manage their eating habits and overall health. In recent years, many young people with T1D are becoming overweight, which can increase their risk of heart problems. The T1DAL program is designed specifically for teens with T1D to improve their eating habits and diabetes management. About 50 teens will participate in this study, with some receiving the T1DAL program for 16 weeks, while others will continue with their usual care at their doctor's office. All participants will have their height, weight, blood sugar levels, eating habits, and mood checked at the beginning and end of the study.
To be eligible for this study, teens must have been diagnosed with type 1 diabetes for at least six months and have a body mass index (BMI) that is higher than 70% for their age and sex. They should also live with a parent or caregiver, have access to a smartphone, and be fluent in English. Participants will receive support tailored to their needs, and even those in the usual care group will have the chance to join a shorter version of the T1DAL program after the study. This program aims to not only improve health outcomes but also to prevent unhealthy eating patterns in teens with T1D.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Teen diagnosed with type 1 diabetes at least 6 months ago
- • Teen's body mass index greater than or equal to the 70th percentile for age and sex
- • Teen lives with parent/caregiver
- • Teen has access to a smart phone
- • Teen and caregiver speak and write in fluent English
- Exclusion Criteria:
- • Teen has a medical condition that precludes them from participating in a group activity and/or any physical activity
- • Teen experiencing psychosis or suicidality
- • Teen lost a significant amount of weight in the 3 months prior to the study
- • Teen currently in another intensive health behavior and lifestyle treatment and/or sees a dietician more than once per month on average
- • Teen currently or planning to become pregnant
- • Teen unwilling to wear a continuous glucose monitor for assessments
- • Teen taking a medication known to impact weight and/or appetite
About The Miriam Hospital
The Miriam Hospital, a leading academic medical center affiliated with Brown University, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. Renowned for its commitment to medical excellence, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes across various specialties, including cardiology, oncology, and infectious diseases. With a focus on translating research findings into practice, The Miriam Hospital fosters collaborations among multidisciplinary teams to enhance the quality of care and promote health equity within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jenny Warnick, PhD
Principal Investigator
The Miriam Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported